Literature DB >> 24653589

Torsade de pointes as a reperfusion arrhythmia following intravenous thrombolytic therapy.

Venkatesh Tekur1.   

Abstract

Many types of cardiac arrhythmias have been noted following acute myocardial infarction. Polymorphic ventricular arrhythmias (polymorphic ventricular tachycardia and ventricular fibrillation) related to an acute myocardial infarction generally strike during the hyperacute phase, are clearly related to ischaemia and are not associated with a long QT interval time. Pause-dependent Torsade de pointes has been reported following acute myocardial infarction and this arrhythmia generally occurs 3-11 days after the onset of acute myocardial infarction and none has been reported during the hyperacute phase. Torsade de pointes - a specific ventricular tachycardia with specific characteristics has been described in hypokalemia, hypomagnesaemia, during Quinidine therapy, and while using phenothiazines and tricyclic antidepressants. It is reported following liquid protein diet, brady-arrhythmias [especially III° AV Block], sick-sinus syndromes. Torsade de pointes either pause-dependent or pause-independent occurring directly as a reperfusion arrhythmia during intravenous thrombolytic therapy has not been reported in the literature to the best of the authors knowledge. Here, an episode of Torsade de pointes as a direct consequence of reperfusion following thrombolytic therapy in a patient of acute myocardial infarction is described.

Entities:  

Keywords:  Acute myocardial infarction; Arrhythmias; Ischaemia; Thrombolytic therapy; Torsade de pointes

Year:  2014        PMID: 24653589      PMCID: PMC3953692          DOI: 10.1016/j.jcdr.2014.01.007

Source DB:  PubMed          Journal:  J Cardiovasc Dis Res        ISSN: 0975-3583


  9 in total

Review 1.  ST segment resolution as a tool for assessing the efficacy of reperfusion therapy.

Authors:  J A de Lemos; E Braunwald
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

2.  Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction.

Authors:  J W Sayer; R A Archbold; P Wilkinson; S Ray; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

3.  Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.

Authors:  A Halkin; A Roth; I Lurie; R Fish; B Belhassen; S Viskin
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

4.  A mechanism of torsades de pointes in a canine model.

Authors:  G H Bardy; R M Ungerleider; W M Smith; R E Ideker
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

5.  Limitation of infarct size with thrombolytic agents--electrocardiographic indexes.

Authors:  S Goldberg; P Urban; A Greenspon; B Berger; P Walinsky; B Muza; V Kusiak; P R Maroko
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

6.  Polymorphous ventricular tachycardia associated with acute myocardial infarction.

Authors:  C L Wolfe; C Nibley; A Bhandari; K Chatterjee; M Scheinman
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

7.  Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction.

Authors:  Masaya Kato; Keigo Dote; Shota Sasaki; Hiroaki Takemoto; Seiji Habara; Daiji Hasegawa
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Potential electrophysiologic mechanisms responsible for dysrhythmias associated with reperfusion of ischemic myocardium.

Authors:  P B Corr; F X Witkowski
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

9.  A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

Authors: 
Journal:  N Engl J Med       Date:  1986-06-05       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.